Diabetes: The Future of a Chronic Disease Research Paper

Diabetes: The future of a chronic disease

The number of cases of type II diabetes has seen a dramatic increase in recent years, both in the United States and worldwide. The primary reasons for this increase are generally attributed to increased consumption of high-sugar, high-starch, and highly caloric food and a lack of exercise. The International Diabetes Foundation estimates that "one in 10 of the world's population will have diabetes by 2035" (Greenberg 2013). Diabetes is "the sixth leading cause of death in the United States" alone (Diabetes disparities among racial and ethnic minorities, 2001, AHRQ). Addressing this national and global epidemic is essential given the common, conventional wisdom in public health that "people will make the healthy choice when the healthy choice is the easy choice" (Greenberg 2013). In the developed, developing, and even the minimally developed world, it is increasingly easy to eat foods associated with triggering the disorder and to engage in lifestyle practices that exacerbate risk factors (Greenberg 2013).

Treatments

The goal of all forms of diabetes treatment is to stabilize blood glucose levels, which requires careful monitoring. The types of treatments suggested for patients with type II diabetes vary depending upon the stages of the disorder and the severity of the case. For patients with 'pre-diabetes' or high blood sugar and associated risk factors not deemed to be serious enough to warrant a full diagnosis, changes in eating habits and exercise may be suggested before medication is prescribed.

Insulin remains one of the most common treatments for diabetes. Insulin may be injected or "delivered through a small tube (catheter) that is placed under the skin (usually in the abdomen)" called a pump (Diabetes mellitus treatment, 2013, UCSF Health). A variety of types of insulin may be used, including rapid-acting, short-acting, intermediate-acting, and long-acting (Diabetes mellitus treatment, 2013, UCSF Health). Oral medications may also be prescribed with or instead of insulin which "improve the effectiveness of the body's natural insulin, reduce blood sugar production, increase insulin production and inhibit blood sugar absorption" (Diabetes mellitus treatment, 2013, UCSF Health). New, recent drugs have been approved which operate on areas of the body other than the pancreas and the liver, the main organs associated with diabetes. New medications "focus action on hormones called incretins" and "have an added bonus of promoting weight loss" (Spotlight on new diabetes treatments, 2013, Joslin Diabetes Center). This reflects a new understanding of how glucose is regulated, not merely "as a conversation between a few key players: the pancreas, the liver, muscle and fat" but also through "hormone[s] from the skeleton" which "influence how the body handles sugar" (Schaffer 2013).

Technology

Although diabetes is a growing epidemic with serious health consequences, one 'good' aspect of…